Industry update from AusBiotech and PwC
Thursday, 03 May, 2012
AusBiotech’s CEO, Dr Anna Lavelle and PricewaterhouseCoopers’ (PwC) Partner, Craig Lawn, sat down to discuss the state of the biotechnology and life sciences sector on webcast, including the impact of the R&D Tax Credit, changes in the market for capital as well as current and emerging trends.
View the webcast here.
The video is a regular production to coincide with the quarterly release of PwC’s BioForum and the latest edition was edition 39 Q3FY12. BioForum reports on the Australian and US pharmaceutical, biotechnology and medical devices markets and the broader life sciences industry.
As well as reviewing market performance, BioForum covers initial and secondary capital raisings, clinical milestones, partnerships and mergers and acquisitions.
This edition of the webcast features:
- Reflection on the past year [4:33 MIN]
-
- Impact of R&D Tax Credit [4:49 MIN]
-
- Changes in the market for capital [3:44 MIN]
-
- Trends [6:26 MIN]
Intense grief linked to higher risk of death for a decade
Researchers have found that bereaved people with persistent high levels of intense grief use more...
COVID vaccine candidate protects against multiple variants
By targeting features shared by a range of coronaviruses, the vaccine is designed to offer...
Stevia leaf extract has potential as an anticancer treatment
When fermented with bacteria isolated from banana leaves, stevia extract kills off pancreatic...
